Extended trial tracks weight loss drug's lasting effects
NCT ID NCT06671821
Summary
This study followed 81 obese participants who had already completed a previous trial of HRS-7535 weight loss tablets. Researchers tracked them for an additional 32 weeks to check long-term safety and see if weight loss benefits continued. The study measured side effects, weight changes, waist circumference, and metabolic improvements over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC WEIGHT MANAGEMENT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Chinese PLA General Hospital
Beijing, Beijing Municipality, 100039, China
Conditions
Explore the condition pages connected to this study.